Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Shares Issued: 2013-2025

Historic Shares Issued for Fortress Biotech (FBIO) over the last 11 years, with Sep 2025 value amounting to $1.3 million.

  • Fortress Biotech's Shares Issued rose 123.77% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 22.49%. This contributed to the annual value of $3.7 million for FY2024, which is 82.95% up from last year.
  • Fortress Biotech's Shares Issued amounted to $1.3 million in Q3 2025, which was up 103.63% from -$35.0 million recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Shares Issued ranged from a high of $36.0 million in Q1 2025 and a low of -$35.0 million during Q2 2025.
  • Moreover, its 3-year median value for Shares Issued was $568,000 (2024), whereas its average is $701,455.
  • Within the past 5 years, the most significant YoY rise in Fortress Biotech's Shares Issued was 3,926.85% (2025), while the steepest drop was 1,911.18% (2025).
  • Fortress Biotech's Shares Issued (Quarterly) stood at $6.3 million in 2021, then plummeted by 95.22% to $303,000 in 2022, then slumped by 104.95% to -$15,000 in 2023, then surged by 2,366.67% to $340,000 in 2024, then soared by 123.77% to $1.3 million in 2025.
  • Its Shares Issued was $1.3 million in Q3 2025, compared to -$35.0 million in Q2 2025 and $36.0 million in Q1 2025.